IKOS CIF’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-2,982
Closed -$253K 208
2015
Q4
$253K Buy
2,982
+2,295
+334% +$190K 0.77% 56
2015
Q3
$57K Sell
687
-1,248
-64% -$105K 0.17% 154
2015
Q2
$162K Sell
1,935
-1,319
-41% -$101K 0.53% 82
2015
Q1
$240K Buy
+3,254
New +$232K 0.55% 87
2014
Q4
Sell
-5,181
Closed -$343K 285
2014
Q3
$343K Sell
5,181
-3,198
-38% -$202K 0.49% 91
2014
Q2
$524K Buy
+8,379
New +$500K 1.67% 16
2014
Q1
Sell
-300
Closed -$15K 266
2013
Q4
$15K Sell
300
-40,850
-99% -$2.05M 0.04% 209
2013
Q3
$2.09M Buy
41,150
+27,743
+207% +$1.45M 2.54% 3
2013
Q2
$666K Buy
+13,407
New +$730K 1.24% 22

Other funds holding LLY

IKOS CIF's LLY Position: Q1 2016 in Review

IKOS CIF sold out of Eli Lilly (LLY) in Q1 2016, closing a stake of 2,982 shares — an estimated $253K sold.

IKOS CIF first reported a position in LLY in Q2 2013 and held it in 9 quarters. The position peaked at $2.09M in Q3 2013. 1,151 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

  • IKOS CIF reported no remaining Eli Lilly position as of Q1 2016 after selling out during the quarter.
  • IKOS CIF sold 2,982 Eli Lilly shares in Q1 2016, an estimated $253K.
  • IKOS CIF first reported a position in Eli Lilly in Q2 2013 and held it in 9 quarters.
  • IKOS CIF's Eli Lilly position peaked at $2.09M in Q3 2013.
  • 1,151 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on IKOS CIF's 13F filing for Q1 2016, filed 13 May 2016.